<DOC>
	<DOCNO>NCT02958995</DOCNO>
	<brief_summary>The purpose study evaluate whether treatment pioglitazone associate risk incident cancer 10 common site cohort participant recognize diabetes along assessment association diabetes severity cancer risk .</brief_summary>
	<brief_title>Epidemiologic Study Of Diabetes And Cancer Risk</brief_title>
	<detailed_description>The study enroll large population approximately 252467 participant . This epidemiology study diabetes cancer risk expansion study would include estimation cancer rate among KPNC member without diabetes relative risk cancer associate diagnosis diabetes . The study include diabetes participant KPNC member 1997 2011 . It also include subset participant take 1996/7 diabetes survey Member Health Survey ( MHS ) 1993 , 1999 , 2001 2003 . This multi-center trial conduct United States America . The overall time participate study approximately 15.5 year . The participant followed-up January 1 , 1997 December 31 , 2011 .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1. KPNC diabetes registry Diabetes Mellitus ( DM ) registry , age 40 year old member KPNC January 1 , 1997 prior diagnosis cancer interest .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Drug Therapy</keyword>
</DOC>